William Jun Liu
Overview
Explore the profile of William Jun Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
865
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu L, Zheng A, Tang Y, Chai Y, Chen J, Cheng L, et al.
Sci China Life Sci
. 2023 Aug;
66(10):2201-2213.
PMID: 37574525
Coronaviruses (CoVs) have brought serious threats to humans, particularly severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), which continually evolves into multiple variants. These variants, especially Omicron, reportedly escape therapeutic antibodies...
2.
Li L, Chai Y, Peng W, Li D, Sun L, Gao G, et al.
Proc Natl Acad Sci U S A
. 2022 Oct;
119(42):e2210724119.
PMID: 36191180
Influenza virus neuraminidase (NA) is an important target for antiviral development because it plays a crucial role in releasing newly assembled viruses. Two unique influenza-like virus genomes were recently reported...
3.
Shi R, Shan C, Duan X, Chen Z, Liu P, Song J, et al.
Nature
. 2020 May;
584(7819):120-124.
PMID: 32454512
An outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally. Countermeasures are needed to treat and prevent further dissemination of the...
4.
Xiao H, Guo T, Yang M, Qi J, Huang C, Hong Y, et al.
Cell Discov
. 2019 Apr;
5:21.
PMID: 30993000
The isolation of human monoclonal antibodies with broadly neutralizing breadth can provide a promising countermeasure for influenza A viruses infection. Most broadly neutralizing antibodies against influenza A viruses bind to...